Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

NCT00017303 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: carboplatin
DRUG: oglufanide disodium
DRUG: paclitaxel
PROCEDURE: conventional surgery

Sponsor

Cytran